Evidence map›Paper›PMID 34588993›Full record

ReviewFrontiers in physiology2021

Dysbiosis, Host Metabolism, and Non-communicable Diseases: Trialogue in the Inborn Errors of Metabolism.

Chiara Montanari, Sara Parolisi, Elisa Borghi, Lorenza Putignani, Giulia Bassanini, Juri Zuvadelli, Cristina Bonfanti, Albina Tummolo, Carlo Dionisi Vici, Giacomo Biasucci and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Chiara MontanariDepartment of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
Sara ParolisiUOS Metabolic and Rare Diseases, AORN Santobono, Naples, Italy.
Elisa BorghiDepartment of Health Science, University of Milan, Milan, Italy.
Lorenza PutignaniDepartment of Diagnostic and Laboratory Medicine, Unit of Microbiology and Diagnostic Immunology, Unit of Microbiomics and Multimodal Laboratory Medicine Research Area, Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Giulia BassaniniDepartment of Health Science, University of Milan, Milan, Italy.
Juri ZuvadelliClinical Department of Pediatrics, ASST Santi Paolo e Carlo, San Paolo Hospital, University of Milan, Milan, Italy.
Cristina BonfantiRare Metabolic Disease Unit, Pediatric Department, Fondazione MBBM, San Gerardo Hospital, Monza, Italy.
Albina TummoloMetabolic Diseases and Clinical Genetics Unit, Children's Hospital Giovanni XXIII, Bari, Italy.
Carlo Dionisi ViciDivision of Metabolism, Bambino Gesù Children's Hospital, Rome, Italy.
Giacomo BiasucciDepartment of Paediatrics & Neonatology, Guglielmo da Saliceto Hospital, Piacenza, Italy.
Alberto BurlinaDivision of Inborn Metabolic Diseases, Department of Diagnostic Services, University Hospital of Padua, Padua, Italy.
Maria Teresa CarboneUOS Metabolic and Rare Diseases, AORN Santobono, Naples, Italy.
Elvira VerduciDepartment of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
University of Milan · ITBambino Gesù Children's Hospital · ITAzienda Ospedaliera San Gerardo · ITGuglielmo da Saliceto Hospital · ITOspedale Pediatrico Giovanni XXIII · ITOspedale San Paolo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inborn errors of metabolism (IEMs) represent a complex system model, in need of a shift of approach exploring the main factors mediating the regulation of the system, internal or external and overcoming the traditional concept of biochemical and genetic defects. In this context, among the established factors influencing the metabolic flux, i.e., diet, lifestyle, antibiotics, xenobiotics, infectious agents, also the individual gut microbiota should be considered. A healthy gut microbiota contributes in maintaining human health by providing unique metabolic functions to the human host. Many patients with IEMs are on special diets, the main treatment for these diseases. Hence, IEMs represent a good model to evaluate how specific dietary patterns, in terms of macronutrients composition and quality of nutrients, can be related to a characteristic microbiota associated with a specific clinical phenotype ("enterophenotype"). In the present review, we aim at reporting the possible links existing between dysbiosis, a condition reported in IEMs patients, and a pro-inflammatory status, through an altered "gut-liver" cross-talk network and a major oxidative stress, with a repercussion on the health status of the patient, increasing the risk of non-communicable diseases (NCDs). On this basis, more attention should be paid to the nutritional status assessment and the clinical and biochemical signs of possible onset of comorbidities, with the goal of improving the long-term wellbeing in IEMs. A balanced intestinal ecosystem has been shown to positively contribute to patient health and its perturbation may influence the clinical spectrum of individuals with IEMs. For this, reaching eubiosis through the improvement of the quality of dietary products and mixtures, the use of pre-, pro- and postbiotics, could represent both a preventive and therapeutic strategy in these complex diseases.

Indexed as

dietenterophenotypegut-liver axisinborn errors of metabolismmicrobiotanon-communicable diseases

Identifiers

PMID34588993
PMCPMC8475650
OpenAlexW3198619954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.